Opdivo Prices, Coupons and Patient Assistance Programs
Opdivo (nivolumab) is a member of the anti-PD-1 monoclonal antibodies drug class and is commonly used for Colorectal Cancer, Head and Neck Cancer, Hepatocellular Carcinoma, and others.
Opdivo Prices
This Opdivo price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Opdivo intravenous solution (10 mg/mL) is around $1,154 for a supply of 4 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Intravenous Solution
| Quantity | Per unit | Price |
|---|---|---|
| 4 milliliters | $288.62 | $1,154.50 |
| 10 milliliters | $287.20 | $2,871.99 |
| 24 milliliters | $286.65 | $6,879.49 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
Print NowThe free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Opdivo Coupons and Rebates
Opdivo offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Opdivo BMS Oncology Co-Pay Assistance Program: Enrolled patients who have commercial insurance may pay no more than $25 per prescription with savings of up to $25,000 per year; for additional information contact the program at 800-861-0048.
| Applies to: | Opdivo |
| Number of uses: | 12 times within calendar year |
| Expires | December 31, 2020 |
Opdivo/Yervoy (Regimen) BMS Oncology Co-Pay Assistance Program: Enrolled patients who have commercial insurance may pay no more than $25 per prescription with savings of up to $25,000 per year; for additional information contact the program at 800-861-0048.
| Applies to: | Opdivo Yervoy Regimen |
| Number of uses: | 12 times within calendar year |
| Expires | December 31, 2020 |
Patient Assistance Programs for Opdivo
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: HealthWell Foundation Copay Program
Elligibility requirements:
- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
Applicable drugs:
- Opdivo (nivolumab) Injection; IV
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:
- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
- Opdivo (nivolumab) Injection; IV
Provider: BMS Access Support (Oncology)
Elligibility requirements:
- Contact program for details.
- Not disclosed
- Varies
- Must be residing in the US or Puerto Rico
- *This program provides the screening for the Bristol-Myers Squibb Patient Assistance Foundation (BMSPAF) Oncology Patient Assistance Program. This program also provides copay assistance.
Applicable drugs:
- Opdivo (nivolumab) Injection; IV
- Opdivo Yervoy Regimen (nivolumab and ipilimumab) Injection; IV infusion
Provider: Bristol Myers Squibb (BMS) Patient Support Program (Expanded: COVID-19)
Elligibility requirements:
- Determined case by case
- Not disclosed
- FDA-approved diagnosis
- The patient must also be residing in the US.
- Eligibility determined on a case-by-case basis. Contact program for details: 1-800-721-8909
Applicable drugs:
- Opdivo (nivolumab) Injection; IV
- Opdivo Yervoy Regimen (nivolumab and ipilimumab) Injection; IV infusion
More about Opdivo (nivolumab)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Compare Alternatives
- En Español
- 44 Reviews
- Drug class: anti-PD-1 monoclonal antibodies
- FDA Approval History
